Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Prithiv J Prasad"'
Autor:
Ioannis M Zacharioudakis, Fainareti N Zervou, Prithiv J Prasad, Yongzhao Shao, Atreyee Basu, Kenneth Inglima, Scott A Weisenberg, Maria E Aguero-Rosenfeld
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242399 (2020)
The Infectious Diseases Society of America has identified the use of SARS-CoV-2 genomic load for prognostication purposes as a key research question. We designed a retrospective cohort study that included adult patients with COVID-19 pneumonia who ha
Externí odkaz:
https://doaj.org/article/04698c6ff4ec47ebb0b036a93566c566
Autor:
Ralf Duerr, Hao Zhou, Takuya Tada, Dacia Dimartino, Christian Marier, Paul Zappile, Guiqing Wang, Jonathan Plitnick, Sara B. Griesemer, Roxanne Girardin, Jessica Machowski, Sean Bialosuknia, Erica Lasek-Nesselquist, Samuel L. Hong, Guy Baele, Meike Dittmann, Mila B. Ortigoza, Prithiv J. Prasad, Kathleen McDonough, Nathaniel R. Landau, Kirsten St George, Adriana Heguy
Publikováno v:
iScience, Vol 26, Iss 2, Pp 106075- (2023)
Summary: The emergence of recombinant viruses is a threat to public health, as recombination may integrate variant-specific features that together result in escape from treatment or immunity. The selective advantages of recombinant SARS-CoV-2 isolate
Externí odkaz:
https://doaj.org/article/585eec9eafc5429bbcaa9a950f5d24d1
Autor:
Prithiv J. Prasad, Jordan Poles, Ioannis M. Zacharioudakis, Yanina Dubrovskaya, Dinuli Delpachitra, Eduardo Iturrate, Sigridh Muñoz-Gómez
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Background and objective: With the coronavirus disease 2019 (COVID-19) pandemic, rates of in-hospital antimicrobial use increased due to perceived bacterial and fungal coinfections along with COVID-19. We describe the incidence of these coi
Externí odkaz:
https://doaj.org/article/e4c956a7bfdb494298c428e6683e9b70
Autor:
Ralf Duerr, Hao Zhou, Takuya Tada, Dacia Dimartino, Christian Marier, Paul Zappile, Guiqing Wang, Jonathan Plitnick, Sara B. Griesemer, Roxanne Girardin, Jessica Machowski, Sean Bialosuknia, Erica Lasek-Nesselquist, Samuel L. Hong, Guy Baele, Meike Dittmann, Mila B. Ortigoza, Prithiv J. Prasad, Kathleen McDonough, Nathaniel R. Landau, Kirsten St. George, Adriana Heguy
Publikováno v:
bioRxiv
SummaryBackgroundThe emergence of recombinant viruses is a threat to public health. Recombination of viral variants may combine variant-specific features that together catalyze viral escape from treatment or immunity. The selective advantages of reco
Autor:
Prithiv J. Prasad, Gary P. Wormser
Publikováno v:
Pathogens. 11:1051
Although tafenoquine was highly effective for eliminating microscopically detectable parasitemia in mouse models of Babesia microti infection, all of the mice which were assessed developed a relapse of infection, except for those which had been treat
Autor:
Maria E Aguero-Rosenfeld, Scott A. Weisenberg, Fainareti N. Zervou, Prithiv J. Prasad, Ioannis M. Zacharioudakis, Atreyee Basu, Yongzhao Shao, Kenneth Inglima
Publikováno v:
Open Forum Infectious Diseases
Background The Infectious Diseases Society of America has identified the potential use of SARS-CoV-2 genomic load for prognostication purposes as a key research question. Methods We designed a retrospective cohort study that included adult patients w
Autor:
Prithiv J. Prasad, Ioannis M. Zacharioudakis, Fainareti N. Zervou, Yongzhao Shao, Maria E Aguero-Rosenfeld, Kenneth Inglima, Atreyee Basu, Scott A. Weisenberg
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0242399 (2020)
PLoS ONE, Vol 15, Iss 11, p e0242399 (2020)
The Infectious Diseases Society of America has identified the use of SARS-CoV-2 genomic load for prognostication purposes as a key research question. We designed a retrospective cohort study that included adult patients with COVID-19 pneumonia who ha
Autor:
Mark J. Mulligan, Gabriel A. Robbins, Ellie Carmody, Jaishvi Eapen, Yi Li, Alexander Hrycko, Vanessa Raabe, Brooklyn Henderson, Dinuli Delpachitra, Yanina Dubrovskaya, Jonathan S. Austrian, Morris Jrada, Martin Backer, Prithiv J. Prasad, Jack DeHovitz, Camila Delgado, Andrea B. Troxel, Robert J. Ulrich
Publikováno v:
Open Forum Infectious Diseases
Background Effective therapies to combat coronavirus 2019 (COVID-19) are urgently needed. Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the clinical benefit of HCQ i
Autor:
Prithiv J. Prasad, Ioannis M. Zacharioudakis, Kenneth Inglima, Fainareti N. Zervou, Atreyee Basu, Maria E Aguero-Rosenfeld, Scott A. Weisenberg
RationaleThe Infectious Diseases Society of America has identified the use of SARS-CoV-2 genomic load for prognostication purposes as a key research question.ObjectivesWe explored the SARS-CoV-2 genomic load as a risk factor for adverse patient outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c0d2fa784ded50eeb729b7f26bb5ac3
https://doi.org/10.1101/2020.07.02.20145151
https://doi.org/10.1101/2020.07.02.20145151
Autor:
Atreyee Basu, Scott A. Weisenberg, Kenneth Inglima, Maria E Aguero-Rosenfeld, Prithiv J. Prasad, Ioannis M. Zacharioudakis, Fainareti N. Zervou
Publikováno v:
Open Forum Infectious Diseases
Background SARS-CoV-2, the cause of COVID-19 pneumonia, is associated with heterogenous presentations ranging from asymptomatic infection to severe respiratory failure. We explored the association of SARS-CoV-2 genomic load as a risk factor for adver